Back to comparisons

Comparison

Bacopa Monnieri vs Reishi

FieldBacopa MonnieriReishi
Categoryadaptogenadaptogen
Dose range300–600mg1000–3000mg
Half-life4h
Onset
EvidenceEVIDENCEAEVIDENCEB
Safety●●●●●●●●●●
Legal (US)USOTCUSOTC
PubMed refs540460

The comparison in plain English

Auto-generated from data

Bacopa Monnieri and Reishi are both in the adaptogen category respectively. Bacopa Monnieri Ayurvedic herb (Bacopa monnieri) with the strongest natural-nootropic evidence base for memory acquisition and retention. Reishi Medicinal mushroom (Ganoderma lucidum) traditionally used for sleep, immunity, and longevity.

Bottom line

Bacopa Monnieri (evidence A, safety 5/5) has a weaker evidence base than Reishi (evidence B, safety 5/5). Bacopa Monnieri has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose Bacopa Monnieri if

Bacopa Monnieri is the better fit when your goal aligns with its mechanism (Active bacosides A and B increase dendritic branching in the CA3 region of the hippocampus, the structural change that underlies improved memory consolidation) and the dose range (300–600mg) suits your protocol. Half-life is 4h.

Choose Reishi if

Reishi is the better fit when your goal aligns with its mechanism (Beta-glucans (the polysaccharide fraction) modulate innate and adaptive immunity through TLR-4 receptor binding) and the dose range (1000–3000mg) suits your protocol. Half-life is —h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →